Toyofumi Suzuki

Dissolution tests for self-setting calcium phosphate cement-containing nifedipine.

Investigation of transport mechanism of pentazocine across the blood-brain barrier using the in situ rat brain perfusion technique.

Investigation on the influx transport mechanism of pentazocine at the blood-brain barrier in rats using the carotid injection technique.

Involvement of P-glycoprotein in blood-brain barrier transport of pentazocine in rats using brain uptake index method.

Enhancement of water solubility of fullerene by cogrinding with mixture of cycloamyloses, novel cyclic alpha-1,4-glucans, via solid-solid mechanochemical reaction.

Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.

In vivo evidence for the efflux transport of pentazocine from the brain across the blood-brain barrier using the brain efflux index method.

P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier.

Molecular complex consisting of two typical external medicines: intermolecular interaction between indomethacin and lidocaine.

Effect of permeation enhancers on the in vitro percutaneous absorption of pentazocine.

Formulation and in vitro evaluation of pentazocine transdermal delivery system.

Nanoparticle processing in the solid state dramatically increases the cell membrane permeation of a cholesterol-lowering drug, probucol.

Characterization of multicomponent crystal formed between indomethacin and lidocaine.

Blood-brain barrier transport of naloxone does not involve P-glycoprotein-mediated efflux.

Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.

Homogeneous nanoparticles to enhance the efficiency of a hydrophobic drug, antihyperlipidemic probucol, characterized by solid-state NMR.

Synergistic effect of isopropyl myristate and glyceryl monocaprylate on the skin permeation of pentazocine.

Involvement of an influx transporter in the blood-brain barrier transport of naloxone.

Effect of beta-cyclodextrin on the degradation rate of amoxicillin in acidic solution.

[Blood-brain barrier transport of opioid analgesics].

Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.

Pharmaceutical evaluation of steroidal ointments by ATR-IR chemical imaging: distribution of active and inactive pharmaceutical ingredients.

Blood-brain barrier transport of an essential amino acid after cerebral ischemia reperfusion injury.

Comparative pharmaceutical evaluation of brand and generic clobetasone butyrate ointments.

Novel pharmaceutical cocrystal consisting of paracetamol and trimethylglycine, a new promising cocrystal former.

Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.

Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine.

Enhanced dissolution and skin permeation profiles of epalrestat with β-cyclodextrin derivatives using a cogrinding method.

Enhancement of nose-to-brain delivery of hydrophilic macromolecules with stearate- or polyethylene glycol-modified arginine-rich peptide.

Comparison of the relative stability of pharmaceutical cocrystals consisting of paracetamol and dicarboxylic acids.

[Retrospective Analysis of Factors Decreasing the Efficacy of Tazobactam/Piperacillin for Pneumonia in Elderly Patients].

Mixtures of betamethasone butyrate propionate ointments and heparinoid oil-based cream: Physical stability evaluation.

Molecular State of Active Pharmaceutical Ingredients in Ketoprofen Dermal Patches Characterized by Pharmaceutical Evaluation.